Belgium · Delayed Price · Currency is EUR Hyloris Pharmaceuticals Statistics
Total Valuation
EBR:HYL has a market cap or net worth of EUR 104.16 million. The enterprise value is 96.89 million.
| Market Cap | 104.16M |
| Enterprise Value | 96.89M |
Important Dates
The last earnings date was Thursday, September 24, 2026.
| Earnings Date | Sep 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EBR:HYL has 28.00 million shares outstanding. The number of shares has increased by 2.09% in one year.
| Current Share Class | 28.00M |
| Shares Outstanding | 28.00M |
| Shares Change (YoY) | +2.09% |
| Shares Change (QoQ) | -6.52% |
| Owned by Insiders (%) | 7.43% |
| Owned by Institutions (%) | 0.00% |
| Float | 25.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.60 |
| PB Ratio | 4.18 |
| P/TBV Ratio | 5.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.82, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.82 |
| Quick Ratio | 4.64 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -95.83 |
Financial Efficiency
Return on equity (ROE) is -17.29% and return on invested capital (ROIC) is -13.25%.
| Return on Equity (ROE) | -17.29% |
| Return on Assets (ROA) | -11.29% |
| Return on Invested Capital (ROIC) | -13.25% |
| Return on Capital Employed (ROCE) | -22.80% |
| Weighted Average Cost of Capital (WACC) | 7.72% |
| Revenue Per Employee | 181,981 |
| Profits Per Employee | -86,185 |
| Employee Count | 54 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 6.46 |
Taxes
| Income Tax | -212,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.02% in the last 52 weeks. The beta is 0.64, so EBR:HYL's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -39.02% |
| 50-Day Moving Average | 4.36 |
| 200-Day Moving Average | 5.45 |
| Relative Strength Index (RSI) | 30.17 |
| Average Volume (20 Days) | 4,138 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EBR:HYL had revenue of EUR 9.83 million and -4.65 million in losses. Loss per share was -0.17.
| Revenue | 9.83M |
| Gross Profit | 9.28M |
| Operating Income | -6.04M |
| Pretax Income | -4.87M |
| Net Income | -4.65M |
| EBITDA | -5.85M |
| EBIT | -6.04M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 8.74 million in cash and 1.46 million in debt, with a net cash position of 7.27 million or 0.26 per share.
| Cash & Cash Equivalents | 8.74M |
| Total Debt | 1.46M |
| Net Cash | 7.27M |
| Net Cash Per Share | 0.26 |
| Equity (Book Value) | 24.94M |
| Book Value Per Share | 0.93 |
| Working Capital | 12.69M |
Cash Flow
In the last 12 months, operating cash flow was -7.75 million and capital expenditures -84,000, giving a free cash flow of -7.83 million.
| Operating Cash Flow | -7.75M |
| Capital Expenditures | -84,000 |
| Depreciation & Amortization | 192,000 |
| Net Borrowing | -247,000 |
| Free Cash Flow | -7.83M |
| FCF Per Share | -0.28 |
Margins
Gross margin is 94.41%, with operating and profit margins of -61.43% and -47.36%.
| Gross Margin | 94.41% |
| Operating Margin | -61.43% |
| Pretax Margin | -49.52% |
| Profit Margin | -47.36% |
| EBITDA Margin | -59.48% |
| EBIT Margin | -61.43% |
| FCF Margin | n/a |
Dividends & Yields
EBR:HYL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.09% |
| Shareholder Yield | -2.09% |
| Earnings Yield | -4.47% |
| FCF Yield | -7.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for EBR:HYL is 11.23, which is 201.88% higher than the current price. The consensus rating is "Buy".
| Price Target | 11.23 |
| Price Target Difference | 201.88% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 138.15% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBR:HYL has an Altman Z-Score of 16.77 and a Piotroski F-Score of 2.
| Altman Z-Score | 16.77 |
| Piotroski F-Score | 2 |